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ABSTRACT
Objective To investigate the likelihood of having the 
seasonal influenza vaccination during the COVID-19 
pandemic in individuals who were eligible to receive it.
Design We conducted a cross- sectional online survey in 
July 2020. We included predictors informed by previous 
research, in the following categories: sociodemographic 
variables; uptake of influenza vaccine last winter and 
beliefs about vaccination.
Participants 570 participants (mean age: 53.07; 56.3% 
female, 87.0% white) who were eligible for the free 
seasonal influenza vaccination in the UK.
Results 59.7% of our sample indicated they were likely to 
have the seasonal influenza vaccination, 22.1% reported 
being unlikely to have the vaccination and 18.2% were 
unsure. We used logistic regression to investigate variables 
associated with intention to receive a seasonal influenza 
vaccine in the 2020–2021 season. A positive attitude to 
vaccination in general predicted intention to have the 
influenza vaccine in 2020–2021 (OR 1.45, 95% CI 1.19 
to 1.77, p<0.001) but the strongest predictor of intention 
was previous influenza vaccination behaviour (OR 278.58, 
95% CI 78.04 to 994.46, p<0.001).
Conclusions Previous research suggests that increasing 
uptake of the influenza vaccination may help contain a 
COVID-19 outbreak, so steps need to be taken to convert 
intention into behaviour and to reach those individuals 
who reported being unlikely or unsure about having the 
vaccine.
INTRODUCTION
To maximise uptake and help contain subse-
quent COVID-19 and other infectious disease 
outbreaks, we need to understand influences 
on intention to have the influenza vaccina-
tion while COVID-19 is circulating. We report 
findings from a survey conducted in July 2020 
in the UK, which explored participants’ like-
lihood of having the seasonal influenza vacci-
nation in 2020–2021.
The COVID-19 pandemic was declared 
on 11 March 2020. While the first wave of 
the pandemic missed most of the influenza 
season in the Northern hemisphere, a second 
wave has overlapped with the 2020–2021 
season.1 Healthcare systems come under 
considerable strain during a typical influenza 
season; this has been compounded by a large 
number of COVID-19 cases. Recent research 
has modelled the impact of mass influenza 
vaccination on the spread of COVID-19, in 
the event of such an overlap, and suggests 
that increasing uptake of the influenza vacci-
nation would facilitate efforts to contain 
COVID-19 outbreaks.2 In addition, there is 
some evidence to suggest that patients with 
a recent history of influenza or influenza- like 
illnesses are at risk of more severe COVID-
19.3 However, increasing, or even main-
taining, levels of influenza vaccination may be 
problematic if reduced uptake patterns seen 
already in other vaccines also hold for the 
influenza vaccine. For example, the uptake of 
the measles- mumps- rubella (MMR) vaccine 
in England became 19.8% lower in the 3 
weeks after full physical distancing measures 
were introduced in March than it was for the 
same period in 2019.4
The influenza season in the UK runs 
from December until March each year and 
the national vaccination programme starts 
in September. At the time of data collec-
tion, eligibility for the free vaccine through 
the National Health Service (NHS) was the 
same as in previous years, being available 
to children aged 2–11, adults over 65, preg-
nant women, health and social care workers, 
Strengths and limitations of this study
 ► First study to explore seasonal influenza vaccine ac-
ceptability in the UK during the COVID-19 pandemic.
 ► Comprehensive demographical information was 
collected to facilitate statistical analysis of eligible 
subgroups.
 ► Survey measured intention rather than behaviour.
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individuals aged 6 months to 65 years who are in clinical 
at- risk groups (many of which coincide with the COVID-19 
at- risk groups), those living in a residential or nursing 
home and anyone who is the main carer of an older or 
disabled person. In November 2020, the 2020–2021 influ-
enza vaccination programme was extended to all adults 
aged 50 or older as well as to anyone living with someone 
who is at high risk from coronavirus. The vaccination is 
also available privately for a charge through primary care 
and pharmacies to the rest of the population. Despite 
the wide availability of a free vaccine for eligible individ-
uals, uptake varies across the different categories of eligi-
bility; for example, in the 2019–2020 season 72.4% of 65+ 
adults in England were vaccinated compared with 44.9% 
of individuals aged 6 months to 65 years in clinical at- risk 
groups.5
In order to protect people ahead of and during the 
annual influenza season, it might be helpful to under-
stand intention to have a seasonal influenza vaccination 
during the COVID-19 pandemic. To this end, we explored 
participants’ likelihood of having the seasonal influenza 
vaccination as part of a larger cross- sectional study inves-
tigating attitudes towards a potential COVID-19 vaccina-
tion.6 Previous research exploring factors associated with 
seasonal influenza vaccination uptake has identified a 
range of factors that might influence seasonal influenza 
uptake.7 8 In this study, we focused on sociodemographic 
factors such as age, ethnicity and gender, general attitude 
towards vaccination, fear of needles and past behaviour 
(whether individuals previously had a seasonal influenza 
vaccination). We explored these factors in participants 
who were eligible for the free influenza vaccination under 
pre- COVID criteria (in place at the time of data collec-
tion) and conducted a sensitivity analysis in which we 
included all those who were eligible under the pandemic- 
motivated broadened criteria.
MATERIALS AND METHODS
A nationally representative quota sample of 1500 UK 
adults (quotas set on age, gender and ethnicity) was 
recruited through Prolific’s online research panel to 
complete a cross- sectional survey between 14 and 17 July 
2020. Participants were included in this study if they were 
eligible to receive the free influenza vaccine through 
the NHS at the time of data collection (aged 65 years or 
over, pregnant, working in health or social care or in a 
clinical risk group). We did not collect data on whether 
participants were living in a care home or whether they 
were a main carer, and so these eligibility criteria are not 
explicitly represented in our analysis. After providing 
consent, participants were asked to complete the survey, 
which included: sociodemographic questions (eg, age, 
gender, ethnicity, employment status, highest educa-
tional or professional qualification); clinical questions 
(eg, whether they or someone else in their household (if 
applicable) had a chronic illness that made them clinically 
vulnerable to serious illness from COVID-19); questions 
about COVID-19 (eg, whether they were worried about 
catching coronavirus) and questions about a possible 
COVID-19 vaccination (eg, whether they thought most 
people would get a coronavirus vaccination). We also 
asked participants to what extent they agreed that ‘in 
general, vaccination is a good thing’ and to what degree 
they were ‘afraid of needles’ (both on an 11- point scale 
from ‘strongly disagree’ to ‘strongly agree’), and if they 
had been vaccinated for seasonal influenza last winter 
(yes/no). The outcome measure for this study, influenza 
vaccination intention, was measured by asking partici-
pants how likely they would be to have the seasonal influ-
enza vaccine ‘this winter’ (11- point scale, from ‘extremely 
unlikely’ to ‘extremely likely’). Full details of the wider 
study, including survey methodology, are reported else-
where.6 The survey is available in online supplemental file 
1.
Since eligibility for the free influenza vaccine in the 
2020–2021 season was widened after data collection, as a 
sensitivity analysis, we re- ran analyses using these broader 
criteria.
Statistical analysis
In order to identify factors associated with intention to 
receive the seasonal influenza vaccine in the 2020–2021 
season, we used a multivariable logistic regression model, 
based on those respondents expressing a clear intention 
either to have or not to have the vaccine. The predictors 
in the model were specified a priori, based on previous 
research7 8 : sociodemographic variables; uptake of influ-
enza vaccine last winter and beliefs about vaccination 
(value of vaccination in general; afraid of needles); see 
table 1. Odds ratios (ORs) with 95% CIs are reported, 
adjusted for all of the other predictors in the model; in 
addition, the corresponding crude (bivariate) ORs are 
given for the purpose of comparison. We used the Nagelk-
erke pseudo- R2 statistic to express the goodness- of- fit of 
the model. Statistical significance was set at p≤0.05.
Patient and public involvement
Patients or the public were not involved in the design, 
or conduct, or reporting or dissemination plans of this 
research.
RESULTS
At the time of data collection, 570 individuals in our 
sample were eligible for the free influenza vaccine. 
The distribution of influenza vaccination intention was 
bimodal, with the majority of responses clustering at 
both ends of the scale. We therefore dichotomised this 
variable as 0–2 = ‘no’ (n=126; 22.1%) and 8–10 = ‘yes’ 
(n=340; 59.7%) on the 0–10 scale. The 466 respondents 
who expressed a clear intention either to have or not to 
have the seasonal influenza vaccine were included in the 
analysis, and the 104 (18.2%) indeterminate cases were 
not analysed further. The results of the regression analysis 
are shown in table 2.
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A positive attitude to vaccination and previous vaccina-
tion behaviour were significant predictors of intention to 
have the influenza vaccine in the 2020–2021 season. As 
indicated by the large OR, previous influenza vaccination 
behaviour was a markedly stronger predictor.
Sensitivity analysis
We conducted the above analyses based on participants 
who were eligible for the free influenza vaccine at the 
time of data collection. In the intervening time, these 
criteria were broadened. Using the broadened eligibility 
criteria, 1003 respondents were eligible in 2020–2021. Of 
these, 491 (49.0%) respondents expressed a clear inten-
tion to have the vaccine, 291 (29.0%) had a clear inten-
tion not to have the vaccine and there were 221 (22.0%) 
indeterminate cases. As before, the indeterminate cases 
were not analysed. The results of the sensitivity analysis 
are shown in table 3.
Compared with the main analysis, a somewhat smaller 
percentage of respondents indicated a clear intention to 
be vaccinated (49.0% vs 59.7%), and correspondingly a 
larger percentage not to be vaccinated (29.0% vs 22.1%). 
However, the ORs were of a similar magnitude to those 
in the main analysis and with similar associated p values 
(though with the larger sample size, the OR for age 
became significant), suggesting that while the broader 
eligibility criteria may influence the percentage of indi-
viduals intending to be vaccinated against influenza, they 
have little effect on the predictors of such vaccination 
behaviour.
In both the main analysis and the sensitivity analysis, 
the adjusted and crude ORs were similar, with the excep-
tion of those for ethnicity. For this variable, the ORs 
changed noticeably (and went from being significant to 
non- significant) after adjustment for the other predictors 
in the multivariable model, suggesting that some of the 
explanatory effect of ethnicity was redistributed to other 
predictors in the full model.
DISCUSSION
These findings strongly suggest that individuals who 
had the influenza vaccine in the last influenza season 
were likely to intend to have it again in the 2020–2021 
season. This is consistent with findings from the H1N1 
influenza pandemic7 as well as with findings from studies 
exploring influenza vaccination intentions during the 
COVID-19 pandemic in other countries and regions such 
as Italy9 10 and Catalonia.11 It also aligns with the finding 
that across six countries (USA, Canada, Israel, Japan, 
Spain, Switzerland) parents’ intention to vaccinate their 
child against seasonal influenza was influenced by their 
and their child’s previous influenza vaccination status.12 
However, there are still key issues to address. Vaccination 
intention across all those individuals in our sample who 
were eligible for the vaccine (59.7%) at the time of data 
collection was slightly lower than the reported uptake 
from the last influenza season (64.3%). Furthermore, it 
is likely that actual uptake will be lower than intention 
as a result of the intention- behaviour gap,13 making it 
important that efforts are made to convert positive inten-
tions into uptake. This might be achieved through appro-
priate messaging and special arrangements for vaccine 
delivery, particularly for those who might be shielding 
or at higher risk from COVID-19 and reluctant to attend 
their general practitioner's surgery. Both approaches are 
also likely to be needed to motivate those individuals who 
have not previously had the influenza vaccine and those 
individuals who are eligible for free vaccination but who 
were among respondents in our sample who indicated 
they definitely did not intend to be vaccinated (22.1%) or 
were unsure (18.2%).
Limitations of the current study include that partic-
ipants were reporting intention to be vaccinated rather 
Table 1 Characteristics and attitudes of those respondents 
who expressed a clear intention either to have or not to have 
the influenza vaccine (n=466)
Variable
Age (years): mean (SD); range 53.07 (16.86); 
18–87
Gender*
  Male 203 (43.7)
  Female 262 (56.3)
Ethnicity†
  White 403 (87.0)
  Non- white 60 (13.0)
Qualifications
  Degree equivalent or higher 231 (49.6)
  Other 235 (50.4)
Working‡
  Part- time 58 (12.5)
  Full- time 136 (29.3)
  Not working/other§ 270 (58.2)
Key worker
  Yes 175 (37.6)
  No 291 (62.4)
Influenza vaccination last winter*
  Yes 299 (64.3)
  No 166 (35.7)
In general, vaccination is a good thing 
(0–10 scale): mean (SD)¶
8.78 (2.09)
I am afraid of needles (0–10 scale): mean 
(SD)¶
2.14 (3.17)




§Includes 30 unemployed, 36 furloughed and 157 retired.
¶These variables showed a marked skew.
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than actual vaccination status and that they were 
collected before a COVID-19 vaccination was a reality. 
However, since public health systems globally are likely 
to be managing seasonal influenza against a backdrop 
of COVID-19 for the foreseeable future, we believe these 
data provide useful information to assist with under-
standing the evolving response to national vaccination 
programmes.
The NHS is often overwhelmed during the influ-
enza season, needing, for example, to cancel routine 
operations. The extension of the influenza vaccination 
programme in 2020–2021 to people aged 50 years and 
over and to those living with someone who is at high risk 
from coronavirus may also help decrease the burden of 
the influenza season. Potential carry- over effects into the 
next influenza season (2021–2022 in the UK), in light 
of the current availability of COVID-19 vaccination, and 
ongoing public health and media discussions regarding 
the need for seasonal vaccination programmes for both 
corona and influenza viruses suggest that the current 
dataset can be used as a baseline for future evaluation of 
the uptake of the influenza vaccination within an ever- 
changing context. Increasing uptake of the seasonal 
influenza vaccine in a timely fashion will relieve pressure 
on health services. If this is to be successful, strategies to 
achieve this increase need to be designed now.
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Table 2 Logistic regression analysis of variables associated with intention to receive a seasonal influenza vaccine
Adjusted (crude) OR 95% CI P value
Age (years) 1.02 (1.03) 0.99 to 1.04 0.190
Gender (reference: female) 1.24 (1.37) 0.60 to 2.59 0.565
Ethnicity—white (reference: black and minority ethnic) 0.60 (1.99) 0.23 to 1.53 0.281
Qualifications—degree equivalent or higher (reference: other) 1.52 (0.94) 0.72 to 3.22 0.278
Working (reference: not working/other)
  Part- time 1.12 (0.75) 0.39 to 3.21 0.830
  Full- time 1.51 (0.81) 0.64 to 3.56 0.342
Key worker (reference: not key worker) 0.59 (0.62) 0.27 to 1.31 0.197
Influenza vaccination last winter (reference: no vaccination) 278.58 (273.58) 78.04 to 994.46 <0.001
In general, vaccination is a good thing (0–10 scale) 1.45 (1.57) 1.19 to 1.77 <0.001
I am afraid of needles (0–10 scale) 0.98 (.091) 0.89 to 1.09 0.757
Reference categories for the ORs are shown where appropriate. CIs and p values relate to the adjusted ORs. n=460 (six cases with 
missing data on one or more variables were not analyzed). Nagelkerke R2=0.760.
Table 3 Logistic regression analysis of variables associated with intention to receive a seasonal influenza vaccine, using the 
broadened eligibility criteria introduced in the 2020–2021 season
Adjusted (crude) OR 95% CI P value
Age (years) 1.02 (1.02) 1.00 to 1.04 0.046
Gender (reference: female) 1.24 (1.12) 0.76 to 2.01 0.388
Ethnicity—white (reference: black and minority ethnic) 0.75 (1.73) 0.36 to 1.56 0.443
Qualifications—degree equivalent or higher (reference: other) 1.00 (1.02) 0.62 to 1.59 0.983
Working (reference: not working/other)
  Part- time 0.80 (0.68) 0.40 to 1.58 0.519
  Full- time 1.03 (0.71) 0.58 to 1.81 0.929
Key worker (reference: not key worker) 0.93 (0.83) 0.55 to 1.57 0.776
Influenza vaccination last winter (reference: no vaccination) 281.78 (262.85) 95.35 to 832.72 <0.001
In general, vaccination is a good thing (0–10 scale) 1.54 (1.57) 1.31 to 1.81 <0.001
I am afraid of needles (0–10 scale) 0.98 (0.92) 0.91 to 1.05 0.529
Reference categories for the ORs are shown where appropriate. CIs and p values relate to the adjusted ORs. n=774 (eight cases with missing 
data on one or more variables were not analyzed). Nagelkerke R2=0.716.
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